Topical gel formulations as potential dermal delivery carriers for green-synthesized zinc oxide nanoparticles

• Published in: Drug delivery and translational research
• Main Authors: Hamed, Rania, Obeid, Ruwa Z, Huwaij, Rana Abu, Qattan, Duaa, Shahin, Nisreen Abu
• Format: Journal Article
• Language: English
• Published: United States 05.06.2024
• Subjects: Skin penetration; Doxorubicin HCl; Bigel; PEGylated ZnO NPs; Zinc oxide nanoparticles; Green synthesis; Hydrogel; Oleogel
• ISSN: 2190-3948
• DOI: 10.1007/s13346-024-01642-6

This study aimed to incorporate green-synthesized zinc oxide nanoparticles (ZnO NPs), functionalized with polyethylene glycol (PEG) and linked to doxorubicin (DOX), into various topical gel formulations (hydrogel, oleogel, and bigel) to enhance their dermal delivery. The ZnO NPs were produced using the aqueous extract of the root hair of Phoenix dactylifera. The optimized green-synthesized ZnO NPs, PEGylated and conjugated to DOX, demonstrated a particle size below 100 nm, low polydispersity index, and zeta potential between - 11 and - 19 mV. The UV-Vis spectroscopy analysis confirmed characteristic absorption peaks at 351 and 545 nm for ZnO and DOX, respectively. The transmission electron microscope (TEM) images revealed well-dispersed spherical nanoparticles without aggregation. Additionally, ZnO NPs-loaded gels exhibited uniformity, cohesion, no phase separation, pseudoplastic flow, and viscoelastic properties. The in vitro release studies showed that DOX-PEG-ZnO NPs hydrogel released 99.5% of DOX after 5 h of starting the release. Moreover, the penetration of DOX-PEG-ZnO NPs through excised rat skin was visualized by TEM. In conclusion, the hydrogel formulation containing green-synthesized DOX-PEG-ZnO NPs holds great promise for dermal administration in skin cancer treatment. Furthermore, the release rate and skin penetration of DOX from gels were varied based on the type of gel matrix and corroborated with their corresponding rheological properties.